Disease Models
- Oncology Models
-
Inflammation & Autoimmune Disease Models
- Rheumatoid Arthritis Models
- Glomerulonephritis Models
- Multiple Sclerosis (MS) Models
- Ocular Inflammation Models
- Sjögren's Syndrome Model
- LPS-induced Acute Lung Injury Model
- Peritonitis Models
- Passive Cutaneous Anaphylaxis Model
- Delayed-Type Hypersensitivity (DTH) Models
- Inflammatory Bowel Disease Models
- Systemic Lupus Erythematosus Animal Models
- Oral Mucositis Model
- Asthma Model
- Sepsis Model
- Psoriasis Model
- Atopic Dermatitis (AD) Model
- Scleroderma Model
- Gouty Arthritis Model
- Carrageenan-Induced Air Pouch Synovitis Model
- Carrageenan-Induced Paw Edema Model
- Experimental Autoimmune Myasthenia Gravis (EAMG) Model
- Graft-versus-host Disease (GvHD) Models
-
Cardiovascular Disease Models
- Surgical Models
- Animal Models of Hypertension
- Venous Thrombosis Model
- Atherosclerosis model
- Cardiac Arrhythmia Model
- Hyperlipoidemia Model
- Doxorubicin-induced Heart Failure Model
- Isoproterenol-induced Heart Failure Model
- Arterial Thrombosis Model
- Pulmonary Arterial Hypertension (PAH) Models
- Heart Failure with Preserved Ejection Fraction (HFpEF) Model
-
Neurological Disease Models
- Alzheimer's Disease Modeling and Assays
- Seizure Models
- Parkinson's Disease Models
- Ischemic Stroke Models
- Acute Spinal Cord Injury (ASCI) Model
- Traumatic Brain Injury (TBI) Model
- Hypoxic-Ischemic Encephalopathy (HIE) Model
- Tourette Syndrome (TS) Model
- Amyotrophic Lateral Sclerosis (ALS) Model
- Huntington's Disease (HD) Model
- Intracerebral hemorrhage (ICH) Models
- Pain Models
-
Metabolic Disease Models
- Type 1 Diabetes Mellitus Model
- Type 2 Diabetes Mellitus Model
- Animal Model of Hyperuricemia
-
Nonalcoholic Fatty Liver Disease Model
- High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease (NAFLD) Model
- Methionine and Choline Deficient (MCD) Diet-Induced Nonalcoholic Fatty Liver Disease (NAFLD) Model
- Gubra-Amylin NASH (GAN) Diet-Induced Nonalcoholic Fatty Liver Disease (NAFLD) Model
- Streptozotocin (STZ) & High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease (NAFLD) Model
- High Fat Diet-Induced Obesity Model
- Liver Disease Models
- Rare Disease Models
- Respiratory Disease Models
- Digestive Disease Models
-
Urology Disease Models
- Cisplatin-induced Nephrotoxicity Model
- Unilateral Ureteral Obstruction Model
- 5/6 Nephrectomy Model
- Renal Ischemia-Reperfusion Injury (RIRI) Model
- Diabetic Nephropathy (DN) Models
- Passive Heymann Nephritis (PHN) Model
- Adenine-Induced Chronic Kidney Disease (CKD) Model
- Kidney Stone Model
- Doxorubicin-Induced Nephropathy Model
- Orthopedic Disease Models
- Ocular Disease Models
- Infectious Disease Models
- Skin Disease Models
Ovariectomy (OVX)-Induced Osteoporosis Model
Creative Bioarray stands at the forefront of preclinical research, boasting a diverse array of disease models tailored to meet the demands of various therapeutic areas. For the development of osteoporosis drugs, we offer the ovariectomy (OVX)-induced osteoporosis model. In addition to our OVX model, we also offer a series of clinically relevant assessments that are designed to comprehensively evaluate the therapeutic potential of osteoporosis drugs. We invite you to further explore our services and discover how we can support your preclinical research efforts.
Osteoporosis is an age-related disease manifested by loss of bone density, with postmenopausal women at higher risk of developing the disease. The OVX model is a classic model of osteoporosis. OVX can induce a decrease in estrogen levels and increase the recruitment, differentiation, and survival of osteoclasts so that bone resorption exceeds bone formation, which eventually leads to osteoporosis. The bone mass loss after modeling was mainly trabecular bone loss, which is similar to the bond loss in postmenopausal women.
Our Ovariectomy (OVX)-Induced Osteoporosis Model
- Available Animal
Rat
Mouse - Modeling Method
After anesthetization, animals in the sham group only undergo abdominal incisions. Animals in the osteoporosis group are induced by ovariectomy (OVX) via a midline abdominal incision. - Endpoints
- Body weight
- Histology analysis: H&E staining
- Bone mineral density (BMD)
- Micro-CT
- Serum analysis: estrogen, osteocalcin, alkaline phosphatase (ALP), etc.
- Cytokine analysis
- Other customized endpoints
Example Data
Fig. 1 Changes of serum levels of estrogen (estradiol, E2)
Fig. 2 Istomorphometric analyses of 4th lumbar vertebrae in the sham, OVX-C and OVX-R group: BV/TV (A), Tb.Th. (B), Tb.N. (C), and Tb.S. (D)
In addition, we also provide other osteoporosis models that maybe you are interested in:
Quotation and Ordering
Creative Bioarray takes pride in our extensive expertise in efficacy studies. Our team of highly skilled professionals is committed to providing cutting-edge solutions that accelerate the drug discovery process and enhance the development of innovative therapeutics. If you are interested in our services, please feel free to contact us at any time or submit an inquiry to us directly.
References
- Lee, H.H., et al. Rutin improves bone histomorphometric values by reduction of osteoclastic activity in osteoporosis mouse model induced by bilateral ovariectomy. Journal of Korean Neurosurgical Society, 2020, 63(4): 433.
- Mu, P., et al. Preparation for Animal Models of Osteoporosis: a Systematic Review. 2021.
For research use only. Not for any other purpose.